Live feed08:30:00·39mNEWSReleasevia QuantisnowIGC Pharma Strengthens Regulatory Readiness as Phase 2 CALMA Alzheimer's Trial Approaches Enrollment Closure and Q4 Topline ReadoutByQuantisnow·Wall Street's wire, on your screen.IGC· IGC Pharma Inc.Health Care